Dr Nikola Mitrev

Lecturer
Medicine & Health
School of Clinical Medicine

Dr Nikola Mitrev completed a Bachelor of Medical Science in 2007 and a Bachelor of Medicine, Bachelor of Surgery in 2011, at the University of Sydney. Following this he was a JMO, RMO and BPT at the St George/ Sutherland Hospital network. He attained his Gastroenterology and Hepatology specialist qualifications at the end of 2018, having trained at Concord Hospital, Gosford/ Wyong Hospitals and the Royal Prince Alfred Hospital. In 2019 he further completed a gastroenterology fellowship year at Blacktown hospital with a focus on IBD, where he subsequently stayed on as a consultant. In parallel to his gastroenterology advanced training, Dr Mitrev was awarded a Master’s degree from the University of Sydney for his work in the field of therapeutic drug monitoring-guided biologic drug therapy in IBD. Dr Mitrev has received several academic awards and research grants through the years. He continues to be active in research and medical education. Currently he is a staff specialist at Sutherland hospital and teaches UNSW students.

  • Journal articles | 2025
    Karimi N; Moore AR; Jones A; Lukin A; Pipicella JL; Williams AJ; Ng W; Kanazaki R; Kariyawasam V; Mitrev N; Pandya K; Andrews JM; Connor SJ, 2025, 'On being on the same page: Predictors of gastroenterologist-patient misalignment in inflammatory bowel disease', Patient Education and Counseling, 130, http://dx.doi.org/10.1016/j.pec.2024.108487
    Journal articles | 2024
    Huang D; Rennie M; Krasovec A; Nagubandi S; Liu S; Ge E; Khehra B; Au M; Sivagnanam S; Kwan V; Rogge C; Mitrev N; Kariyawasam V, 2024, 'Impact of cytomegalovirus on outcomes in acute severe ulcerative colitis: a retrospective observational study', Therapeutic Advances in Chronic Disease, 15, http://dx.doi.org/10.1177/20406223241233203
    Journal articles | 2023
    An YK; Lindsay N; Allan N; Khoo E; Fernandes R; Amiss A; Pham H; Wong KF; Ooi SY; Thin L; Lightowler D; Connor SJ; Williams AJ; De Cruz P; Li Wai Suen C; Kariyawasam V; Mitrev N; Ghaly S; Andrews JM; Christensen B; Sparrow MP; White LS; Bryant RV; Ding N; Leong R; Van Langenberg D; Seltenreich H; Subramaniam K; Radford-Smith G; Begun J, 2023, 'P663 Post-ustekinumab induction IL12, IL23, and ustekinumab levels are associated with clinical response in a multi-centre prospective cohort study of Crohn’s disease patients: results from the AURORA Study including ANZIBDC Cohort', Journal of Crohn's and Colitis, 17, pp. i793 - i794, http://dx.doi.org/10.1093/ecco-jcc/jjac190.0793
    Journal articles | 2023
    Karimi N; Lukin A; Moore AR; Pipicella JL; Kanazaki R; Williams AJ; Ng W; Kariyawasam V; Mitrev N; Pandya K; Connor SJ, 2023, 'Adolescents and young adults communicating with gastroenterologists: Variation in inflammatory bowel disease clinical communication', International Journal of Adolescent Medicine and Health, 35, pp. 347 - 361, http://dx.doi.org/10.1515/ijamh-2023-0078
    Journal articles | 2021
    Kariyawasam VC; Mourad FH; Mitrev N; Paramsothy S; Selinger CP; Katelaris PH; Jones B; McDonald C; Barr G; Chapman G; Cowlishaw J; Andrews J; Leong RW, 2021, 'Early thiopurine maintenance is associated with reduced proximal disease progression and colectomy rate in ulcerative colitis', European Journal of Gastroenterology and Hepatology, 33, pp. 1524 - 1532, http://dx.doi.org/10.1097/MEG.0000000000002101
    Journal articles | 2021
    Mitrev N; Huang H; Hannah B; Kariyawasam VC, 2021, 'Review of exclusive enteral therapy in adult Crohn's disease', BMJ Open Gastroenterology, 8, http://dx.doi.org/10.1136/bmjgast-2021-000745
    Journal articles | 2017
    Mitrev N; Kariyawasam V; Leong RW, 2017, 'Editorial: infliximab trough cut-off for perianal Crohn's disease – another piece of the therapeutic drug monitoring-guided infliximab dosing puzzle', Alimentary Pharmacology and Therapeutics, 45, pp. 1279 - 1280, http://dx.doi.org/10.1111/apt.14020
    Journal articles | 2017
    Mitrev N; Leong RW, 2017, 'Therapeutic drug monitoring of anti-tumour necrosis factor-α agents in inflammatory bowel disease', Expert Opinion on Drug Safety, 16, pp. 303 - 317, http://dx.doi.org/10.1080/14740338.2017.1269169
    Journal articles | 2017
    Mitrev N; Vande Casteele N; Seow CH; Andrews JM; Connor SJ; Moore GT; Barclay M; Begun J; Bryant R; Chan W; Corte C; Ghaly S; Lemberg DA; Kariyawasam V; Lewindon P; Martin J; Mountifield R; Radford-Smith G; Slobodian P; Sparrow M; Toong C; van Langenberg D; Ward MG; Leong RW, 2017, 'Review article: consensus statements on therapeutic drug monitoring of anti-tumour necrosis factor therapy in inflammatory bowel diseases', Alimentary Pharmacology and Therapeutics, 46, pp. 1037 - 1053, http://dx.doi.org/10.1111/apt.14368
  • Conference Papers | 2023
    An YK; Lindsay N; Allan N; Khoo E; Fernandes R; Amiss A; Pham H; Wong KF; Ooi SY; Thin L; Lightowler D; Connor SJ; Williams AJ; De Cruz P; Suen CLW; Kariyawasam V; Mitrev N; Ghaly S; Andrews JM; Christensen B; Sparrow MP; White LS; Bryant RV; Ding N; Leong R; Van Langenberg D; Seltenreich H; Subramaniam K; Radford-Smith G; Begun J, 2023, 'Post-ustekinumab induction IL12, IL23, and ustekinumab levels are associated with clinical response in a multi-centre prospective cohort study of Crohn's disease patients: results from the AURORA Study including ANZIBDC Cohort', in JOURNAL OF CROHNS & COLITIS, OXFORD UNIV PRESS, pp. 793 - 794, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000960367601372&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2023
    Karimi N; Lukin A; Moore AR; Pipicella J; Kanazaki R; Williams A-J; Ng W; Kariyawasam V; Mitrev N; Pandya K; Connor S, 2023, 'Talking with emerging adults living with inflammatory bowel disease: A qualitative study of clinical communication in gastroenterology', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 175 - 176
    Conference Papers | 2022
    An Y-K; Lindsay N; Allan N; Khoo E; Amiss A; Moniruzzaman M; Fernandes R; Ooi S-Y; Thin L; Lightowler D; Connor S; Williams A-J; De Cruz P; Suen CLW; Kariyawasam V; Mitrev N; Ghaly S; Andrews JM; Christensen B; Sparrow M; White L; Bryant RV; Ding N; Leong R; Van Langenberg D; Seltenreich H; Subramaniam K; Radford-Smith G; Begun J, 2022, 'Post-induction IL-12/23 levels correlate with clinical response and remission after ustekinumab in a multicenter prospective cohort study of patients with Crohn's disease: Preliminary induction results of the AURORA study, including the Australia New Zealand IBD Consortium Cohort', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 146 - 147, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000852585700223&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2020
    Mitrev N; Nasr M; Segboer H; Corte C; Liu K, 2020, 'PREVALENCE AND IMPACT OF FRAILTY AMONG INFLAMMATORY BOWEL DISEASE OUTPATIENTS', in GUT, BMJ PUBLISHING GROUP, pp. A55 - A55, http://dx.doi.org/10.1136/gutjnl-2020-IDDF.102
    Conference Papers | 2020
    Nasr M; Segboer H; Mitrev N; Corte C; Liu K, 2020, 'Prevalence, risk factors, and impact of frailty among outpatients with inflammatory bowel disease', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 123 - 123, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000589476200177&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2017
    Mitrev N; Vande Casteele N; Seow C; Andrews JM; Connor SJ; Moore G; Barclay M; Begun J; Bryant R; Chan W; Corte C; Ghaly S; Lemberg DA; Kariyawasam V; Lewindon P; Martin J; Mountifield R; Radford-Smith G; Slobodian P; Sparrow M; Toong C; Van Langenberg D; Ward MG; Leong RW, 2017, 'Therapeutic drug monitoring-guided biological drug therapy in inflammatory bowel disease: Consensus statements of the Australian Inflammatory Bowel Disease Association (AIBDA) and Gastroenterological Society of Australia (GESA)', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 136 - 138, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000407897100247&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2016
    Leong RW; Mitrev N; Ko Y, 2016, 'Hygiene Hypothesis: Is the Evidence the Same All over the World?', in Digestive Diseases, pp. 35 - 42, http://dx.doi.org/10.1159/000442922
    Conference Presentations | 2015
    Perry J; Chen A; Collins G; Chang J; Kohler F; Leong RW, 2015, 'Medication non-adherence in inflammatory bowel diseases is significantly associated with disability'